Resultats globals: 3 registres trobats en 0.02 segons.
Articles, 3 registres trobats
Articles 3 registres trobats  
1.
8 p, 1.8 MB Early intravenous nitroglycerin use in prehospital setting and in the emergency department to treat patients with acute heart failure : Insights from the EAHFE Spanish registry / Miró, Òscar (The GREAT (Global Research in Acute Contditions Team) Network) ; Llorens-Soriano, Pere (Hospital General Universitario de Alicante (Alacant, País Valencià)) ; Freund, Y. (Emergency Department. hôpital Pitié-Salpêtrière. Assistance Publique - Hôpitaux 18 de Paris (APHP). Sorbonne Université) ; Davison, Beth A (INSERM U-942 (Biotherapy in the critically ill)) ; Takagi, Koji (INSERM U-942 (Biotherapy in the critically ill)) ; Herrero-Puente, Pablo (Hospital Universitario Central de Asturias) ; Jacob, Javier (Hospital Universitari de Bellvitge) ; Martín-Sánchez, Francisco Javier (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ; Gil, Víctor (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Rossello, Xavier (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ; Alquézar-Arbé, A (Institut d'Investigació Biomèdica Sant Pau) ; Jiménez-Fábrega, Francesc X. (Sistema d'Emergències Mèdiques (Catalunya)) ; Masip, Josep (Universitat de Barcelona) ; Mebazaa, Alexandre (Hôpital Lariboisière, Paris, France) ; Cotter, Gad (INSERM U-942 (Biotherapy in the critically ill))
Background and objective: Although recommended for the treatment of acute heart failure (AHF), the use of intravenous (IV) nitroglycerin (NTG) is supported by scarce and contradicting evidence. In the current analysis, we have assessed the impact of IV NTG administration by EMS or in emergency department (ED) on outcomes of AHF patients. [...]
2021 - 10.1016/j.ijcard.2021.09.031
International Journal of Cardiology, Vol. 344 (january 2021) , p. 127-134  
2.
12 p, 3.6 MB Outcomes of patients with heart failure with preserved ejection fraction discharged on treatment with neurohormonal antagonists after an episode of decompensation / Tost, Josep (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ; Llorens-Soriano, Pere (Hospital General Universitario de Alicante (Alacant, País Valencià)) ; Cotter, Gad (Momentum Research. Durham) ; Davison, Beth A (Momentum Research. Durham) ; Jacob, Javier (Hospital Universitari de Bellvitge) ; Gil, Víctor (Universitat de Barcelona) ; Herrero-Puente, Pablo (Hospital Universitario Central de Asturias) ; Martín-Sánchez, Francisco Javier (Hospital Clínico San Carlos (Madrid)) ; Donea, Ruxandra (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ; Rodríguez, Beatriz (Hospital Universitario Infanta Leonor) ; Lucas-Imbernon, Francisco Javier (Complejo Hospitalario Universitario de Albacete) ; Andueza, Juan Antonio (Hospital General Universitario Gregorio Marañón) ; Mecina, Ana Belén (Hospital Universitario Fundación Alcorcón) ; Torres-Gárate, Raquel (Hospital Universitario Severo Ochoa) ; Piñera, Pascual (Hospital General Universitario Reina Sofía (Múrcia, Múrcia)) ; Alquézar-Arbé, A (Institut d'Investigació Biomèdica Sant Pau) ; Espinosa, Bego (Instituto de Investigación Sanitaria y Biomédica de Alicante) ; Mebazaa, A. (The GREAT network) ; Chioncel, O. (University of Medicine Carol Davila) ; Miró, Òscar (The GREAT network)
Aims: To analyze the frequency with which patients with heart failure with preserved ejection fraction (HFpEF) discharged after an acute heart failure (AHF) episode are treated with antineurohormonal drugs (ANHD), the variables related to ANHD prescription and their relationship with outcomes. [...]
2021 - 10.1016/j.ejim.2021.07.013
European Journal of Internal Medicine, Vol. 94 (december 2021) , p. 73-84  
3.
14 p, 657.9 KB Cardiopoietic cell therapy for advanced ischaemic heart failure : results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial / Bartunek, Jozef (Cardiovascular Center, Onze-Lieve-Vrouwziekenhuis OLV Hospital, Moorselbaan 164, Aalst, B-9300, Aalst, Belgium) ; Terzic, Andre (Mayo Clinic, Center for Regenerative Medicine, Department of Cardiovascular Diseases, 200 First Street SW, Rochester, Minnesota 550905, USA) ; Davison, Beth A. (Momentum Research, Inc, Durham, NC, USA) ; Filippatos, Gerasimos S. (University General Hospital Attikon (Haidari, Grècia)) ; Radovanovic, Slavica (University Hospital Center Bezanijska Kosa, Belgrade, Serbia) ; Beleslin, Branko (University of Belgrade. Cardiology Clinic) ; Merkely, Bela (Semmelweis University. Heart and Vascular Center) ; Musialek, Piotr (Jagiellonian University Department of Cardiac and Vascular Diseases, John Paul II Hospital, Krakow, Poland) ; Wojakowski, Wojciech (Third Division of Cardiology, Medical University of Silesia, Katowice, Poland) ; Andreka, Peter (Gottsegen Gyorgy Hungarian Institute of Cardiology, Budapest, Hungary) ; Horvath, Ivan G. (Heart Institute, University of Pécs, Pécs, Hungary) ; Katz, Amos (Department of Cardiology, Barzilai Medical Center, Israel Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel) ; Dolatabadi, Dariouch (Division of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium) ; El Nakadi, Badih (Division of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium) ; Arandjelovic, Aleksandra (Cardiology Department, Clinical Hospital Zvezdara, Belgrade, Serbia) ; Edes, Istvan (Department of Cardiology, University of Debrecen, Debrecen, Hungary) ; Seferovic, Petar M. (University of Belgrade School of Medicine, Belgrade University Medical Center, Belgrade, Serbia) ; Obradovic, Slobodan (Clinic of Emergency Medicine, Military Medical Academy, School of Medicine, University of Defense, Belgrade, Serbia) ; Vanderheyden, Marc (Cardiovascular Center, Onze-Lieve-Vrouwziekenhuis OLV Hospital, Moorselbaan 164, Aalst, B-9300, Aalst, Belgium) ; Jagic, Nikola (Clinical Center Kragujevac, Kragujevac, Serbia) ; Petrov, Ivo (Department of Cardiology, Angiology, and Electrophysiology, City Clinic Heart and Vascular Institute, Sofia University, Sofia, Bulgaria) ; Atar, Shaul (Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Israel) ; Halabi, Majdi (Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Israel) ; Gelev, Valeri L. (Department of Cardiology, Angiology, and Electrophysiology, City Clinic Heart and Vascular Institute, Sofia University, Sofia, Bulgaria) ; Shochat, Michael K. (Heart Institute, Hillel Yaffe Medical Center, Hadera, Rappaport School of Medicine, Haifa, Israel, Technion) ; Kasprzak, Jaroslaw D. (Medical University of Lodz) ; Sanz-Ruiz, Ricardo (Hospital General Universitario Gregorio Marañón) ; Heyndrickx, Guy R. (Cardiovascular Center, Onze-Lieve-Vrouwziekenhuis OLV Hospital, Moorselbaan 164, Aalst, B-9300, Aalst, Belgium) ; Nyolczas, Noémi (Medical Centre, Hungarian Defense Forces, Budapest, Hungary) ; Legrand, Victor (Department of Cardiology, Centre Hospitalier Universitaire de Liège, Liège, Belgium) ; Guédès, Antoine (Department of Cardiology, Universite Catholique de Louvain, CHU UcL Namur, Yvoir, Belgium) ; Heyse, Alex (Department of Cardiology, AZ Glorieux, Ronse, Belgium) ; Moccetti, Tiziano (Cardiocentro Ticino, Lugano, Switzerland) ; Fernandez Aviles, Francesc (Hospital General Universitario Gregorio Marañón) ; Jimenez-Quevedo, Pilar (Hospital Clínico San Carlos (Madrid)) ; Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Hernandez-Garcia, Jose Maria (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Ribichini, Flavio (Department of Cardiology, University of Verona, Italy) ; Gruchala, Marcin (Department of Cardiology, Medical University of Gdansk, Gdansk, Poland) ; Waldman, Scott A. (Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA) ; Teerlink, John R. (School of Medicine, University of California San Francisco and Section of Cardiology, San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA) ; Gersh, Bernard J. (Mayo Clinic, Center for Regenerative Medicine, Department of Cardiovascular Diseases, 200 First Street SW, Rochester, Minnesota 550905, USA) ; Povsic, Thomas J. (Duke Clinical Research Institute and Duke Medicine, Durham, NC, USA) ; Henry, Timothy D. (Cedars Sinai Heart Institute (Los Angeles, Estats Units d'Amèrica)) ; Metra, Marco (Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University and Spedali Civili, Brescia, Italy) ; Hajjar, Roger J. (Mount Sinai School of Medicine, New York, NY, USA) ; Tendera, Michal (Third Division of Cardiology, Medical University of Silesia, Katowice, Poland) ; Behfar, Atta (Mayo Clinic, Center for Regenerative Medicine, Department of Cardiovascular Diseases, 200 First Street SW, Rochester, Minnesota 550905, USA) ; Alexandre, Bertrand (Celyad, Mont Saint Guibert, Belgium) ; Seron, Aymeric (Celyad, Mont Saint Guibert, Belgium) ; Stough, Wendy Gattis (Departments of Clinical Research and Pharmacy Practice, Campbell University College of Pharmacy and Health Sciences, Cary, NC, USA) ; Sherman, Warren (Celyad, Mont Saint Guibert, Belgium) ; Cotter, Gad (Momentum Research, Inc, Durham, NC, USA) ; Wijns, William (The Lambe Institute for Translational Medicine and Curam, National University of Ireland Galway and Saolta University Healthcare Group, Galway, Ireland) ; Universitat Autònoma de Barcelona
Cardiopoietic cells, produced through cardiogenic conditioning of patients' mesenchymal stem cells, have shown preliminary efficacy. The Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial aimed to validate cardiopoiesis-based biotherapy in a larger heart failure cohort. [...]
2016 - 10.1093/eurheartj/ehw543
European heart journal, Vol. 38 (december 2016) , p. 648-660  

Vegeu també: autors amb noms similars
3 Cotter, Gad
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.